New oral formulation with Diclofenac

In France, 50 mg of diclofenac epolamine granules for oral suspension in sachets have been granted marketing authorisation and are now available. The field of application extends over: short-term symptomatic treatment of acute seizures of extraarticular rheumatism such as scapulo-humerus periarthritis, tendonitis and mucosal inflammation in adolescents (over 15 years of age) and adults; microcrystalline arthritis; arthritis; Low Back Pain (lumbago); Radiculalgia